On the other hand, there are considerable evidence that TAMs induce tumor chemotherapy resistance through the release of inflammatory cytokines and chemokines such as IL-6, CCL18, TNF-α, CCL2, and CXCR4 [18]. The gene discussed is CCL2; the disease is neoplasm.